Chronic lung disease of prematurity (CLD) has risen in importance since the advent of effective care for preterm babies. Factors contributing to CLD include anatomical immaturity, surfactant deficiency, mechanical ventilation, and oxygen therapy.1 Current modes of treatment are only marginally successful in reducing its incidence. 2 Reactive oxygen species and other free radical metabolites have been implicated in the pathogenesis of numerous diseases in both adults and neonates. Toxic effects in the lung, which are presumed to be mediated by free radicals, include: cytotoxic effects on endothelial and epithelial cells of the lung parenchyma,3 and on alveolar macrophages4; inhibition of surfactant synthesis5; inhibition of the pulmonary vascular response to hypoxia6; inhibition of normal lung repair by fibroblasts, thus resulting in altered collagen deposition7; and inhibition of normal lung development resulting in decreased alveolisation.8 Acute lung disease in preterm infants is accompanied by pronounced inflammatory cell migration into the lungs.9 10 In the presence of activated inflammatory cells,9-11 together with high concentrations of inspired oxygen,12 the relative immaturity of most host defence mechanisms, and appropriate conditions for reperfusion lung injury,12 such as re-expansion of collapsed segments, the potential exists for the local generation of reactive oxygen species.
We remain ignorant of the mechanisms which lead to the resolution of respiratory distress syndrome in some infants, while others develop CLD. Bronchoalveolar lavage specimens taken from neonates who have subsequently developed CLD show a persistently increased cell count (mainly neutrophils) in comparison with those who recover without CLD.9 This accumulation of polymorphonuclear cells within the lung may lead to an increase in toxic oxygen metabolites.13 Animal models based on guinea pigs,'4 mice,'5 rats,16 rabbits17 and premature baboons'8 have shown that lung injury comparable with that seen in human CLD can be produced by hyperoxic exposure. These studies suggest that reactive oxygen species have an important role in CLD. However, animal models vary in their biochemical response to hyperoxia.19 20 Thus, although a role for free radicals in lung injury is well established, little is known about the importance of oxygen toxicity in preterm infants.
The observation that the lowest birthweight, least mature infants are most prone to develop CLD is consistent with the idea that immature oxidant defence mechanisms contribute to the onset of CLD. If this is true, an effective means of augmenting the antioxidant defences of the lung could lead to a reduction in the incidence of CLD. We consider the evidence to support these statements.
Production of reactive oxygen species and free radicals Free radicals are very reactive unstable molecular species which can initiate chain reactions to form new free radicals. Although formed as a result of a wide range ofnormal biochemical processes, they are potentially damaging, and several host defence mechanisms are in place to neutralise their effects. Reactive oxygen species are free radicals, but there are other biologically important free radicals, such as thiyl and peroxyl radicals (fig 1) .
Reactive oxygen species are formed during normal cellular metabolism. Stepwise reduction of molecular oxygen to water in the mitochondrial electron transport chain generates the superoxide radical, hydrogen peroxide, and the hydroxyl radical. The cytochrome oxidase system, however, achieves a one step reduction of oxygen to water accounting for more than 90% of oxygen reduction and avoiding major free radical formation. These reactive oxygen species are also produced in activated leucocytes2l involved in inflammatory processes, as a result of phagocytic bactericidal mechanisms22 which are important in host defence, and as a result of eicosanoid metabolism.3
In the presence of free iron H202 (hydrogen peroxide) reacts proteins from neutrophil proteases. Oxygen toxicity is associated with the release of chemotactic factors, producing an influx of polymorphonuclear leucocytes that are stimulated to release toxic oxygen metabolites and elastase. 36 In neonates with RDS the a-i proteinase inhibitor concentration in bronchoalveolar lavage is maximal at 96 hours, the time of peak polymorphonuclear leucocyte numbers as well as peak elastase activity. Those who go on to develop CLD are found to have low a-I proteinase inhibitor concentrations in the face of prolonged polymorphonuclear leucocyte influx and high elastase activity,9 possibly as a result of reactive oxygen metabolites generated by polymorphonuclear leucocytes.
Free radicals can also denature protein and DNA and initiate lipid peroxidation, resulting in an increase in membrane permeability3 and inactivation of surfactant.24 These reactions provide markers of free radical activity and oxidative damage. Lipid peroxidation generates hydroperoxides, endoperoxides, aldehydes (such as 4-hydroxynonenal) and the end products malondialdehyde, ethane, and pentane. Oxidative damage to proteins and DNA results in the formation of protein carbonyls and 8-hydroxydeoxyguanosine, respectively. The only definitive way of demonstrating excessive free radical activity in vivo is by electron spin resonance study of tissues. Unfortunately, this cannot be used at present in clinical practice because of the nature of the spin traps.
In very low birthweight infants a poor clinical outcome is associated with an increased production of breath hydrocarbons which are the products of lipid peroxidation, although the site of origin of breath hydrocarbons is unlikely to be merely within the lungs,37 as there is a correlation between the blood concentration of malondialdhydethiobarbituric acid and respiratory outcome.38 Tissue injury by any preceding cause is believed to accelerate lipid peroxidation reactions in the disrupted tissue. This may be extremely relevant in those neonates in whom barotrauma and insufficient defences against lipid peroxidation could be acting synergistically in the pathogenesis of CLD. There are several possible explanations for this: the amount of vitamin E that can enter cellular lipid membranes may be limited by the membrane lipid composition rather than its supply; administered vitamin E accumulates slowly, taking weeks to achieve small increments in tissue concentrations. 42 The fetus undergoes an abrupt transition from an hypoxic to a relatively hyperoxic environment at birth. In preparation for this, the late gestational maturation of the antioxidant enzyme system is a normal aspect of fetal lung development in mammals.43 A single small study in human lungs suggests that this may also be the case in the human fetus.44 The maturation process parallels that of surfactant. It therefore seems likely that the antioxidant defences of the immature lung will be prepared neither for the hyperoxic environment nor the inflammation found in association with acute respiratory distress.
Prevention of injury due to reactive oxygen species Oxygen induced lung injury may be minimised by a reduction in oxygen exposure, reducing lung inflammation and maximising the antioxidant defence potential of the lung. Pregnant rats treated prenatally with dexamethasone give birth to prematurely born pups with increased lung antioxidant enzymes.45
Antioxidant enzyme induction by prenatal steroids may also occur in human infants, and is suggested by recent studies which show a reduced incidence of CLD in newborns treated prenatally with dexamethasone.2
The additive effect of undernutrition and hyperoxia on the course of pulmonary oxygen toxicity has been repeatedly demonstrated.46
Studies of the effect of protein deficiency on rats exposed to hyperoxia show that the increased mortality is due to a deficiency of sulphur containing amino acids, rather than a result of general protein deficiency.47 The rats with supplemented cysteine were able to increase concentrations of total lung glutathione in response to hyperoxia, whereas the glutathione concentrations in the unsupplemented group remained unchanged. Premature infants may be deficient in cysteine48 and therefore might benefit from supplementation. However, additional cysteine added to non-deficient diets does not significantly increase tolerance to oxygen.47 Low Studies in rats suggest that there is a potential for parenterally administered polyunsaturated fatty acids (PUFA) to serve as free radical scavengers and protect against oxygen induced pulmonary injury.52 This is compatible with Dormandy's theory that 'intracellular PUFA, located in non-critical nonmembrane sites and immediately replaced after their own oxidation, could serve to avidly scavenge excess oxygen radicals and prevent their interaction with critical membrane PUFA'. However, a randomised controlled trial in infants with RDS who were assigned to receive parenteral nutrition that included a lipid
infants who received parenteral nutrition without lipid.53 Because extrapolation from animal models to people is unreliable, additional well designed studies are necessary.
Vitamin A may be particularly important in the regeneration of damaged epithelial cells. One study has shown a beneficial effect if premature infants are supplemented with vitamin A.54
Attention to the nutritional provision of premature infants may therefore improve their outcome. As many of the proteins, vitamins, and minerals take weeks to achieve adequate tissue concentrations, maternal nutrition during pregnancy may also be important.
Augmentation of the antioxidant defence system of the lung (table) The target for therapeutic intervention is the epithelial lining fluid and the epithelium of the airways and alveoli. The systemic route may be successful but is more likely to have unwanted side effects. Topical treatment can lead to high concentrations in the epithelial lining fluid, although technical aspects of aerosol administration to newborn babies are formidable. Cellular uptake may be enhanced by delivering agents in lipo-somal form which results in the intracellular release of the contents of the vesicles after endocytosis.
The incorporation of vitamin E into liposomes can increase the ot tocopherol content of cells 12-fold in six hours. 55 In future this finding may permit rapid augmentation of cell and organ vitamin E during the course of oxidant mediated diseases.
N-Acetylcysteine (NAC) has the capacity to react directly with electrophiles, and thus has antioxidant potential. NAC is readily de-acetylated to form thiol metabolites, including cysteine and glutathione, both of which are antioxidants. Oral and intravenous administration of NAC increase plasma and red cell Glutathione aerosol therapy has been studied in idiopathic pulmonary fibrosis, where it seems to reduce the oxidant burden at the alveolar epithelial surface.60 Tracheal administration of reduced glutathione in liposomes, but not reduced glutathione alone, delays the onset and decreases the severity of lung damage in fasted mice exposed to oxygen.6' However, drug-free liposomes also have a beneficial effect, for reasons that are not clear.
The administration of SOD in various forms has been studied. In a double-blind trial Rosenfeld et al treated 45 
